Skip to main content
. 2017 Mar 15;12(3):e0173358. doi: 10.1371/journal.pone.0173358

Fig 5. Comparison of the plotted proportional meta-analysis, according to ERT regimens, for cerebrovascular complications.

Fig 5

Effect differences were seen due to the non-overlap of the 95% confidence intervals favoring the use of agalsidase beta compared to both untreated patients and agalsidase alfa, as their CIs did not overlap. There was no statistically significance difference between agalsidase alfa and untreated patients, as their CIs overlapped.